Betterlife Pharma
Montreal
About Betterlife Pharma
BetterLife Pharma is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2025)
- Ticker: cnsx:BETR
- Website: abetterlifepharma.com
- Phone: [email protected]
Industries & Categories
Alternative Medicine, Biopharma, Biotechnology, Nutraceutical
Social Profiles
Canonical: https://fsome.com/organization/betterlife-pharma-22555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.